NCT04797767 2026-04-17Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid NeoplasmsUniversity of WashingtonPhase 1/2 Recruiting62 enrolled
NCT05735184 2026-03-13A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AMLKura Oncology, Inc.Phase 1 Recruiting420 enrolled